Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Olumide O. Okunoye"'
Autor:
Nnaemeka C. Iriemenam, Fehintola A. Ige, Stacie M. Greby, Olumide O. Okunoye, Mabel Uwandu, Maureen Aniedobe, Stephnie O. Nwaiwu, Nwando Mba, Mary Okoli, Nwachukwu E. William, Akipu Ehoche, Augustine Mpamugo, Andrew Mitchell, Kristen A. Stafford, Andrew N. Thomas, Temitope Olaleye, Oluwaseun O. Akinmulero, Ndidi P. Agala, Ado G. Abubakar, Ajile Owens, Sarah E. Gwyn, Eric Rogier, Venkatachalam Udhayakumar, Laura C. Steinhardt, Diana L. Martin, McPaul I. Okoye, Rosemary Audu
Publikováno v:
Journal of Clinical Virology Plus, Vol 3, Iss 1, Pp 100139- (2023)
Objectives: Determining an accurate estimate of SARS-CoV-2 seroprevalence has been challenging in African countries where malaria and other pathogens are endemic. We compared the performance of one single-antigen assay and three multi-antigen SARS-Co
Externí odkaz:
https://doaj.org/article/8b24489d36bf43309ea71d4cce80fefc
Autor:
Nnaemeka C. Iriemenam, Augustine Mpamugo, Akudo Ikpeazu, Olumide O. Okunoye, Edewede Onokevbagbe, Orji O. Bassey, Jelpe Tapdiyel, Matthias A. Alagi, Chidozie Meribe, Mukhtar L. Ahmed, Gabriel Ikwulono, Rose Aguolu, Gregory Ashefor, Charles Nzelu, Akipu Ehoche, Babatunde Ezra, Christine Obioha, Ibrahim Baffa Sule, Oluwasanmi Adedokun, Nwando Mba, Chikwe Ihekweazu, Manhattan Charurat, Brianna Lindsay, Kristen A. Stafford, Dalhatu Ibrahim, Mahesh Swaminathan, Ernest L. Yufenyuy, Bharat S. Parekh, Sylvia Adebajo, Alash’le Abimiku, McPaul I. Okoye
Publikováno v:
PLOS Global Public Health, Vol 2, Iss 11 (2022)
Human Immunodeficiency Virus (HIV) diagnosis remains the gateway to HIV care and treatment. However, due to changes in HIV prevalence and testing coverage across different geopolitical zones, it is crucial to evaluate the national HIV testing algorit
Externí odkaz:
https://doaj.org/article/c4d40b4dd0a14773848018df984750a5
Autor:
Audu RA; Nigerian Institute of Medical Research, Lagos, Nigeria., Stafford KA; Center for International Health, Education and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Steinhardt L; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Musa ZA; Nigerian Institute of Medical Research, Lagos, Nigeria., Iriemenam N; Division of Global HIV/AIDS and Tuberculosis, Center for Global Health, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Ilori E; Nigeria Centre for Disease Control, Abuja, Nigeria., Blanco N; Center for International Health, Education and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Mitchell A; Center for International Health, Education and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Hamada Y; Institute for Global Health, University College London, London, United Kingdom., Moloney M; Center for International Health, Education and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Iwara E; Center for International Health, Education and Biosecurity, University of Maryland, Baltimore, Abuja, Nigeria., Abimiku A; Center for International Health, Education and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Ige FA; Nigerian Institute of Medical Research, Lagos, Nigeria., William NE; Nigeria Centre for Disease Control, Abuja, Nigeria., Igumbor E; Nigeria Centre for Disease Control, Abuja, Nigeria.; School of Public Health, University of Western Cape, Cape Town, South Africa., Ochu C; Nigeria Centre for Disease Control, Abuja, Nigeria., Omoare AA; Nigeria Centre for Disease Control, Abuja, Nigeria., Okunoye O; Division of Global HIV/AIDS and Tuberculosis, Center for Global Health, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Greby SM; Division of Global HIV/AIDS and Tuberculosis, Center for Global Health, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Rangaka MX; Institute for Global Health, University College London, London, United Kingdom., Copas A; Institute for Global Health, University College London, London, United Kingdom., Dalhatu I; Division of Global HIV/AIDS and Tuberculosis, Center for Global Health, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Abubakar I; Institute for Global Health, University College London, London, United Kingdom., McCracken S; Division of Global HIV/AIDS and Tuberculosis, Center for Global Health, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Alagi M; Division of Global HIV/AIDS and Tuberculosis, Center for Global Health, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Mba N; Nigeria Centre for Disease Control, Abuja, Nigeria., Anthony A; Nigeria Centre for Disease Control, Abuja, Nigeria., Okoye M; Division of Global HIV/AIDS and Tuberculosis, Center for Global Health, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Okoi C; Nigeria Centre for Disease Control, Abuja, Nigeria., Ezechi OC; Nigerian Institute of Medical Research, Lagos, Nigeria., Salako BL; Nigerian Institute of Medical Research, Lagos, Nigeria., Ihekweazu C; Nigeria Centre for Disease Control, Abuja, Nigeria.
Publikováno v:
PLOS global public health [PLOS Glob Public Health] 2022 Jun 17; Vol. 2 (6), pp. e0000363. Date of Electronic Publication: 2022 Jun 17 (Print Publication: 2022).
Autor:
Iriemenam NC; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Ige FA; Microbiology Department, Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Greby SM; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Mpamugo A; University of Maryland, Baltimore, Abuja, Nigeria., Abubakar AG; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Dawurung AB; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Esiekpe MK; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Thomas AN; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Okoli MU; National Reference Laboratory, Nigeria Centre for Disease Control Abuja, Abuja, Nigeria., Awala SS; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Ugboaja BN; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Achugbu CC; National Reference Laboratory, Nigeria Centre for Disease Control Abuja, Abuja, Nigeria., Odoh I; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Nwatu FD; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Olaleye T; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Akayi L; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Akinmulero OO; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Dattijo J; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Onokevbagbe E; University of Maryland, Baltimore, Abuja, Nigeria., Okunoye O; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Mba N; National Reference Laboratory, Nigeria Centre for Disease Control Abuja, Abuja, Nigeria., Agala NP; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Uwandu M; Microbiology Department, Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Aniedobe M; Microbiology Department, Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Stafford KA; University of Maryland School of Medicine, Baltimore, MD, United States of America., Abimiku A; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.; University of Maryland School of Medicine, Baltimore, MD, United States of America., Hamada Y; Institute for Global Health, University College London, London, United Kingdom., Swaminathan M; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Okoye MI; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Steinhardt LC; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Audu R; Microbiology Department, Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Publikováno v:
PloS one [PLoS One] 2022 Apr 01; Vol. 17 (4), pp. e0266184. Date of Electronic Publication: 2022 Apr 01 (Print Publication: 2022).
Autor:
Steinhardt LC; Malaria Branch, Division of Malaria and Parasitic Diseases, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Ige F; Center for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Iriemenam NC; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Greby SM; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Hamada Y; Institute for Global Health, University College London, London, United Kingdom., Uwandu M; Clinical Diagnostic Laboratory, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Aniedobe M; Center for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Stafford KA; Center for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Abimiku A; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.; International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria., Mba N; National Reference Laboratory, Nigeria Center for Disease Control, Abuja, Nigeria., Agala N; International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria.; National Reference Laboratory, Nigeria Center for Disease Control, Abuja, Nigeria., Okunoye O; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Mpamugo A; University of Maryland, Baltimore, Abuja, Nigeria., Swaminathan M; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Onokevbagbe E; University of Maryland, Baltimore, Abuja, Nigeria., Olaleye T; International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria., Odoh I; International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria., Marston BJ; Division of Malaria and Parasitic Diseases, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Okoye M; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Abubakar I; Institute for Global Health, University College London, London, United Kingdom., Rangaka MX; Institute for Global Health, University College London, London, United Kingdom., Rogier E; Malaria Branch, Division of Malaria and Parasitic Diseases, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Audu R; Center for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Publikováno v:
Journal of clinical microbiology [J Clin Microbiol] 2021 Jun 18; Vol. 59 (7), pp. e0051421. Date of Electronic Publication: 2021 Jun 18.